Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Media Networks Sydney Pty Limited
WARNING LETTER
•Media Networks Sydney Pty Limited•July 10, 2025

Media Networks Sydney Pty Limited – FDA Warning Letter, Jul 10, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Media Networks Sydney Pty. Limited on September 16, 2025, concerning its over-the-counter (OTC) drug manufacturing operations. The company was registered with the FDA from March 6, 2024, to July 11, 2025, during which import records showed a shipment of its "Combantrin Chocolate Squares" into the United States on April 11, 2024.

The primary issues stemmed from the company"s non-compliance with the Federal Food, Drug, and Cosmetic (FD&C) Act. Specifically, Media Networks Sydney Pty. Limited failed to respond to multiple electronic requests for records and information, initiated on May 28, 2024, and continuing through April 4, 2025, under Section 704(a)(4) of the Act. Furthermore, the company refused an announced inspection on December 18, 2024, stating it had not yet begun production, a claim contradicted by U.S. import records. Refusing access to records and delaying an inspection are prohibited acts under Section 301(e) and can lead to drugs being deemed adulterated under Section 501(j) of the FD&C Act.

As a consequence, the FDA placed all drugs manufactured by the firm on Import Alert 66-79 on July 10, 2025, making them subject to detention or refusal of admission into the U.S. The company subsequently deregistered. Media Networks Sydney Pty. Limited is required to respond in writing within 15 working days, either providing information for FDA"s assessment or requesting to schedule an inspection to demonstrate compliance with quality assurance and other applicable requirements.

Company
Media Networks Sydney Pty Limited
Inspection date
July 10, 2025
Product type
Other
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · eeff497b-57aa-40e2-9484-a071c174e8eb

Violation Codes7
21 U.S.C. 374(a)(4)FD&C Act 704(a)(4)FD&C Act 301(e)21 U.S.C. 331(e)FD&C Act 501(j)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Media Networks Sydney Pty Limited
  • WARNING_LETTER - 2024-08-20August 20, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Media Networks Sydney Pty Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.